Half-year report · HY

Period2025-04-01 → 2025-09-30
Filed2025-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥70.0bn2025-04-01 → 2025-09-30Cons.Net sales
Revenue¥137.4bn2024-04-01 → 2025-03-31Cons.Net sales (5-year summary)
Revenue¥68.4bn2024-04-01 → 2024-09-30Cons.Net sales
Operating income¥3.5bn2025-04-01 → 2025-09-30Cons.Operating income
Operating income¥3.7bn2024-04-01 → 2024-09-30Cons.Operating income
Ordinary income¥3.5bn2025-04-01 → 2025-09-30Cons.Ordinary income
Ordinary income¥6.7bn2024-04-01 → 2025-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥3.5bn2024-04-01 → 2024-09-30Cons.Ordinary income
Profit before tax¥3.8bn2025-04-01 → 2025-09-30Cons.Income before income taxes
Profit before tax¥3.5bn2024-04-01 → 2024-09-30Cons.Income before income taxes
Net income (owners)¥2.4bn2025-04-01 → 2025-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥4.0bn2024-04-01 → 2025-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.9bn2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent
Net income¥2.4bn2025-04-01 → 2025-09-30Cons.Profit loss
Net income¥1.9bn2024-04-01 → 2024-09-30Cons.Profit loss
Total assets¥68.9bnat 2025-09-30Cons.Assets
Total assets¥70.1bnat 2025-03-31Cons.Assets
Total assets¥70.5bnat 2024-09-30Cons.Total assets (5-year summary)
Total liabilities¥45.0bnat 2025-09-30Cons.Liabilities
Total liabilities¥47.4bnat 2025-03-31Cons.Liabilities
Net assets / equity¥23.9bnat 2025-09-30Cons.Net assets
Net assets / equity¥22.7bnat 2025-03-31Cons.Net assets
Net assets / equity¥21.5bnat 2024-09-30Cons.Net assets (5-year summary)
Cash and deposits¥11.0bnat 2025-09-30Cons.Cash and deposits
Cash and deposits¥14.0bnat 2025-03-31Cons.Cash and deposits
Cash & equivalents¥11.0bnat 2025-09-30Cons.Cash and cash equivalents
Cash & equivalents¥14.0bnat 2025-03-31Cons.Cash and cash equivalents
Cash & equivalents¥12.3bnat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥15.1bnat 2024-03-31vCons.Cash and cash equivalents
Operating cash flow¥1.0bn2025-04-01 → 2025-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥5.9bn2024-04-01 → 2025-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥381m2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥113m2025-04-01 → 2025-09-30Cons.Net cash provided by used in investment activities
Investing cash flow¥347m2024-04-01 → 2025-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow¥720m2024-04-01 → 2024-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥3.9bn2025-04-01 → 2025-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥7.3bn2024-04-01 → 2025-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥3.9bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥25.62025-04-01 → 2025-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥42.942024-04-01 → 2025-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥20.992024-04-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio34.7%at 2025-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio32.4%at 2025-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio30.5%at 2024-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2025-04-01 → 2025-09-30¥22m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2025-04-01 → 2025-09-30¥22m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2025-04-01 → 2025-09-30¥3m
Children Businessreportable segmentrevenue2025-04-01 → 2025-09-30¥5.3bn
Children Businessreportable segmentrevenue external2025-04-01 → 2025-09-30¥5.3bn
Children Businessreportable segmentsegment profit2025-04-01 → 2025-09-30−¥39m
Elderly Care Businessreportable segmentrevenue2025-04-01 → 2025-09-30¥28.1bn
Elderly Care Businessreportable segmentrevenue external2025-04-01 → 2025-09-30¥28.1bn
Elderly Care Businessreportable segmentsegment profit2025-04-01 → 2025-09-30¥1.5bn
Medical Businessreportable segmentrevenue2025-04-01 → 2025-09-30¥36.6bn
Medical Businessreportable segmentrevenue external2025-04-01 → 2025-09-30¥36.6bn
Medical Businessreportable segmentsegment profit2025-04-01 → 2025-09-30¥2.1bn
—segment totalrevenue2025-04-01 → 2025-09-30¥70.0bn
—segment totalrevenue external2025-04-01 → 2025-09-30¥70.0bn
—segment totalsegment profit2025-04-01 → 2025-09-30¥3.5bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2024-04-01 → 2024-09-30¥23m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2024-04-01 → 2024-09-30¥23m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2024-04-01 → 2024-09-30¥4m
Children Businessreportable segmentrevenue2024-04-01 → 2024-09-30¥5.0bn
Children Businessreportable segmentrevenue external2024-04-01 → 2024-09-30¥5.0bn
Children Businessreportable segmentsegment profit2024-04-01 → 2024-09-30¥78m
Elderly Care Businessreportable segmentrevenue2024-04-01 → 2024-09-30¥27.8bn
Elderly Care Businessreportable segmentrevenue external2024-04-01 → 2024-09-30¥27.8bn
Elderly Care Businessreportable segmentsegment profit2024-04-01 → 2024-09-30¥1.3bn
Medical Businessreportable segmentrevenue2024-04-01 → 2024-09-30¥35.5bn
Medical Businessreportable segmentrevenue external2024-04-01 → 2024-09-30¥35.5bn
Medical Businessreportable segmentsegment profit2024-04-01 → 2024-09-30¥2.3bn
—segment totalrevenue2024-04-01 → 2024-09-30¥68.4bn
—segment totalrevenue external2024-04-01 → 2024-09-30¥68.4bn
—segment totalsegment profit2024-04-01 → 2024-09-30¥3.7bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 475
ItemContextValueUnit
Number of shares heldInterimInstant_No2MajorShareholdersMember8089000
Shareholding ratioInterimInstant_No2MajorShareholdersMember0.0881
Number of shares heldInterimInstant_No3MajorShareholdersMember7690200
Shareholding ratioInterimInstant_No3MajorShareholdersMember0.0837
Number of shares heldInterimInstant_No4MajorShareholdersMember4709500
Shareholding ratioInterimInstant_No4MajorShareholdersMember0.0513
Number of shares heldInterimInstant_No5MajorShareholdersMember2440382
Shareholding ratioInterimInstant_No5MajorShareholdersMember0.0266
Number of shares heldInterimInstant_No6MajorShareholdersMember2050000
Shareholding ratioInterimInstant_No6MajorShareholdersMember0.0223
Number of shares heldInterimInstant_No7MajorShareholdersMember1999302
Shareholding ratioInterimInstant_No7MajorShareholdersMember0.0218
Number of shares heldInterimInstant_No8MajorShareholdersMember1200600
Shareholding ratioInterimInstant_No8MajorShareholdersMember0.0131
Number of shares heldInterimInstant_No9MajorShareholdersMember1079006
Shareholding ratioInterimInstant_No9MajorShareholdersMember0.0118
Number of shares heldInterimInstant_No10MajorShareholdersMember940000
Shareholding ratioInterimInstant_No10MajorShareholdersMember0.0102
Number of shares heldInterimInstant62003090
Shareholding ratioInterimInstant0.6752
Number of shares issued shares voting rightsInterimInstant_SharesWithNoVotingRightsMember-
Number of shares issued shares voting rightsInterimInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember-
Number of shares issued shares voting rightsInterimInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of voting rights issued shares voting rightsInterimInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of shares issued shares voting rightsInterimInstant_OrdinarySharesSharesWithFullVotingRightsTreasurySharesEtcMember2912900
Number of shares issued shares voting rightsInterimInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember91786300
Number of voting rights issued shares voting rightsInterimInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember917863
Number of shares issued shares voting rightsInterimInstant_OrdinarySharesSharesLessThanOneUnitMember42593
Number of shares issued shares voting rightsInterimInstant94741793
Number of voting rights issued shares voting rightsInterimInstant917863
Number of shares held in own name treasury shares etcInterimInstant_Row1Member2912900
Number of shares held in others names treasury shares etcInterimInstant_Row1Member-
Total number of shares held treasury shares etcInterimInstant_Row1Member2912900
Shareholding ratio treasury shares etcInterimInstant_Row1Member0.0307
Number of shares held in own name treasury shares etcInterimInstant2912900
Number of shares held in others names treasury shares etcInterimInstant-
Total number of shares held treasury shares etcInterimInstant2912900
Shareholding ratio treasury shares etcInterimInstant0.0307
Cash and depositsPrior1YearInstant14004000000JPY
Cash and depositsInterimInstant10989000000JPY
Accounts receivable tradePrior1YearInstant14983000000JPY
Accounts receivable tradeInterimInstant17085000000JPY
SuppliesPrior1YearInstant142000000JPY
SuppliesInterimInstant150000000JPY
Other caPrior1YearInstant2064000000JPY
Other caInterimInstant2862000000JPY
Allowance for doubtful accounts caPrior1YearInstant-28000000JPY
Allowance for doubtful accounts caInterimInstant-21000000JPY
Current assetsPrior1YearInstant31166000000JPY
Current assetsInterimInstant31067000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2025-03-31pass rounding
balance sheet identityconsolidated 2025-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2025-03-31pass
statement vs summary · net assetsconsolidated 2025-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2025-04-01/2025-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2025-04-01/2025-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2025-04-01/2025-09-30pass
statement vs summary · total assetsconsolidated 2025-03-31pass
statement vs summary · total assetsconsolidated 2025-09-30pass